Loading…
Sumitomo Chemical India (SUMICHEM)₹339.85−0.60%Pesticides & Agrochemicals
In the Sep 2026 quarter (consolidated), Sumitomo Chemical India reported sales of ₹910 Cr, down 2.5% from Sep 2025, and net profit of ₹157 Cr, down 11.9% year on year. For the year to Mar 2026, sales were ₹3,250 Cr and net profit ₹545 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 544 | 676 | 842 | 992 | 644 | 681 | 1,061 | 934 | 570 | 687 | 1,067 | 910 |
| Expenses | 475 | 533 | 676 | 741 | 535 | 559 | 836 | 710 | 467 | 549 | 828 | 720 |
| Operating Profit | 66.20 | 140 | 161 | 246 | 106 | 120 | 219 | 218 | 99.31 | 134 | 233 | 187 |
| OPM % | 12.0% | 21.0% | 19.0% | 25.0% | 17.0% | 18.0% | 21.0% | 23.0% | 18.0% | 20.0% | 22.0% | 20.0% |
| Other Income | 26.99 | 26.99 | 25.99 | 31.02 | 31.03 | 31.99 | 39.04 | 39.01 | 21.02 | 32.04 | 74.03 | 44.06 |
| Interest | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 | 1.99 |
| Depreciation | 15.98 | 17.01 | 14.99 | 15.99 | 18.99 | 16.01 | 15.99 | 17.01 | 16.98 | 16.98 | 16.99 | 16.98 |
| Profit before tax | 75.23 | 150 | 171 | 261 | 117 | 133 | 242 | 239 | 102 | 148 | 289 | 211 |
| Tax % | 27.0% | 26.0% | 26.0% | 26.0% | 25.0% | 25.0% | 26.0% | 25.0% | 25.0% | 25.0% | 26.0% | 25.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −12.03 | 0.00 | 20.06 | 0.00 |
| Net Profit | 55.21 | 110 | 127 | 194 | 87.27 | 100 | 178 | 179 | 76.24 | 111 | 216 | 157 |
| EPS (Rs) | 1.09 | 2.19 | 2.53 | 3.84 | 1.73 | 1.99 | 3.56 | 3.55 | 1.51 | 2.22 | 4.29 | 3.14 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,921 | 2,236 | 2,434 | 2,654 | 3,071 | 3,526 | 2,852 | 3,159 | 3,250 | 3,234 |
| Expenses | 1,689 | 1,933 | 2,084 | 2,153 | 2,453 | 2,839 | 2,363 | 2,510 | 2,562 | 2,564 |
| Operating Profit | 220 | 292 | 336 | 489 | 604 | 669 | 476 | 635 | 673 | 654 |
| OPM % | 11.0% | 13.0% | 14.0% | 18.0% | 20.0% | 19.0% | 17.0% | 20.0% | 21.0% | 20.2% |
| Other Income | 30.03 | 1.01 | −20.03 | 18.99 | 27.01 | 45.03 | 95.98 | 120 | 131 | 171 |
| Interest | 4.99 | 3.99 | 6.98 | 6.99 | 7.98 | 5.98 | 5.99 | 6.99 | 7.98 | 7.96 |
| Depreciation | 23.98 | 27.98 | 40.98 | 46.99 | 44.96 | 52.01 | 62.03 | 66.01 | 65.93 | 67.93 |
| Profit before tax | 222 | 261 | 268 | 454 | 577 | 656 | 505 | 682 | 730 | 750 |
| Tax % | 34.0% | 36.0% | 23.0% | 24.0% | 26.0% | 23.0% | 26.0% | 26.0% | 25.0% | — |
| Exceptional items | 0.00 | −4.01 | −21.04 | 6.01 | 5.01 | 17.04 | 17.04 | 20.06 | 33.11 | 8.03 |
| Net Profit | 145 | 167 | 206 | 346 | 425 | 504 | 371 | 508 | 545 | 561 |
| EPS (Rs) | — | — | 4.09 | 6.91 | 8.48 | 10.05 | 7.39 | 10.11 | 10.87 | 11.16 |
| Dividend payout % | 0.0% | 38.0% | 18.0% | 12.0% | 12.0% | 12.0% | 80.0% | 12.0% | 12.0% | — |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 275 | 275 | 498 | 498 | 499 | 498 | 499 | 498 | 499 |
| Reserves | 679 | 774 | 723 | 1,042 | 1,428 | 1,881 | 1,942 | 2,400 | 2,891 |
| Borrowings | 9.99 | 19.98 | 35.93 | 32.95 | 37.97 | 33.93 | 29.95 | 51.90 | 62.94 |
| Other Liabilities | 691 | 788 | 845 | 1,093 | 1,040 | 948 | 837 | 1,005 | 1,016 |
| Total Liabilities | 1,655 | 1,856 | 2,101 | 2,666 | 3,005 | 3,361 | 3,309 | 3,955 | 4,469 |
| Fixed Assets | 267 | 279 | 319 | 309 | 390 | 430 | 563 | 556 | 577 |
| CWIP | 9.01 | 8.01 | 10.01 | 14.01 | 35.04 | 71.02 | 23.02 | 27.99 | 20.03 |
| Investments | 0.00 | 0.00 | 86.12 | 291 | 357 | 239 | 347 | 525 | 1,155 |
| Other Assets | 1,379 | 1,568 | 1,685 | 2,052 | 2,222 | 2,621 | 2,376 | 2,846 | 2,717 |
| Inventories | 607 | 678 | 586 | 751 | 935 | 886 | 608 | 702 | 763 |
| Trade receivables | 553 | 673 | 852 | 850 | 845 | 948 | 718 | 785 | 738 |
| Cash & equivalents | 74.04 | 50.99 | 94.06 | 242 | 79.08 | 303 | 183 | 43.01 | 121 |
| Total Assets | 1,655 | 1,856 | 2,101 | 2,666 | 3,005 | 3,361 | 3,309 | 3,955 | 4,469 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 47.07 | 78.12 | 221 | 426 | 222 | 389 | 758 | 453 | 447 |
| Cash from investing activity | −40.06 | −35.04 | −118 | −283 | −290 | −327 | −420 | −393 | −333 |
| Cash from financing activity | 6.99 | −64.91 | −60.93 | −46.97 | −62.90 | −72.86 | −336 | −67.93 | −82.92 |
| Net cash flow | 14.98 | −22.95 | 41.88 | 95.74 | −131 | −9.98 | 0.00 | −7.98 | 30.92 |
| Capex | 43.12 | 40.15 | 38.16 | 43.16 | 114 | 120 | 64.24 | 29.11 | 44.12 |
| Free cash flow | 4.01 | 39.10 | 184 | 384 | 109 | 271 | 696 | 424 | 404 |
| CFO / OP % | 58.9% | 57.0% | 90.0% | 109.0% | 60.9% | 83.9% | 186.9% | 96.9% | 91.0% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 105 | 110 | 128 | 117 | 101 | 98 | 92 | 91 | 83 |
| Inventory days | 202 | 192 | 145 | 184 | 197 | 156 | 135 | 152 | 165 |
| Days payable | 176 | 136 | 122 | 145 | 109 | 86 | 96 | 106 | 86 |
| Cash conversion cycle | 133 | 166 | 152 | 157 | 189 | 169 | 132 | 137 | 163 |
| Working capital days | 113 | 115 | 108 | 94 | 126 | 135 | 171 | 179 | 153 |
| ROCE % | — | 27.0% | 25.9% | 32.0% | 33.0% | 28.9% | 20.0% | 24.9% | 21.9% |
For the Sep 2026 quarter, Sumitomo Chemical India reported sales of ₹910 Cr, down 2.5% year on year and net profit of ₹157 Cr, down 11.9% year on year. The operating margin was 20.0%.
Sumitomo Chemical India's sales for the year to Mar 2026 were ₹3,250 Cr; over the last twelve months they were ₹3,234 Cr.
Net profit for the year to Mar 2026 was ₹545 Cr, and ₹561 Cr over the last twelve months. Earnings per share over the same trailing period were ₹11.16.
Sumitomo Chemical India reported borrowings of ₹62.94 Cr at Mar 2026, against cash and equivalents of ₹121 Cr.
Cash from operations was ₹447 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹404 Cr.